Cargando…

Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine in a Multicenter Cohort of Nursing Home Residents Receiving Maintenance Hemodialysis

Detalles Bibliográficos
Autores principales:	Labriola, Laura, Scohy, Anaïs, Van Regemorter, Elliott, Robert, Arnaud, Clerbaux, Gaëtan, Gillerot, Gaelle, Pochet, Jean-Michel, Biller, Pauline, De Schuiteneer, Manuel, Morelle, Johann, Yombi, Jean Cyr, Kabamba, Benoît, Rodriguez-Villalobos, Hector, Jadoul, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the National Kidney Foundation, Inc. 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342865/ https://www.ncbi.nlm.nih.gov/pubmed/34364905 http://dx.doi.org/10.1053/j.ajkd.2021.07.004

Ejemplares similares

Humoral responses to BNT162b2 SARS-CoV-2 and hepatitis B vaccines are associated in patients on maintenance hemodialysis: a single-centre experience in Belgium
por: Van Regemorter, Elliott, et al.
Publicado: (2021)

High response rate to BNT162b2 mRNA COVID-19 vaccine among self-care dialysis patients
por: Georgery, Hélène, et al.
Publicado: (2021)

Low rates of humoral response to BNT162b2 SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases treated with rituximab
por: Demoulin, Nathalie, et al.
Publicado: (2021)

A comparative analysis of the outcomes of patients with influenza or COVID-19 in a tertiary hospital in Belgium
por: Wallemacq, Silvio, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 infection in health care workers of a teaching hospital in Belgium: self-reported occupational and household risk factors for seropositivity
por: Scohy, Anaïs, et al.
Publicado: (2021)

Impact of therapeutic plasma exchange on acquired vaccinal anti-SARS-CoV-2 antibodies
por: Lambert, Catherine, et al.
Publicado: (2022)

Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case Series
por: Fernandes, Guillaume, et al.
Publicado: (2022)

In Reply to ‘Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations’
por: Fernandes, Guillaume, et al.
Publicado: (2022)

COVID-19 Infection in Kidney Transplant Recipients: A Single-Center Case Series of 22 Cases From Belgium
por: Devresse, Arnaud, et al.
Publicado: (2020)

Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy
por: De Greef, Julien, et al.
Publicado: (2021)

Severe hypercalcaemia early after kidney transplantation in two patients with severe secondary hyperparathyroidism previously treated with etelcalcetide
por: Dachy, Guillaume, et al.
Publicado: (2021)

Evaluation of a commercial interferon-γ release assay for the detection of SARS-CoV-2 T-cell response after vaccination
por: Saad Albichr, Imane, et al.
Publicado: (2023)

SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule
por: Werion, Alexis, et al.
Publicado: (2020)

Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases
por: Manolache, Narcis-George, et al.
Publicado: (2022)

Clinical characteristics and humoral immune response in healthcare workers with COVID-19 in a teaching hospital in Belgium
por: Vandercam, G., et al.
Publicado: (2020)

Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2
por: Bauernfeind, Stilla, et al.
Publicado: (2021)

Serum uric acid, disease severity and outcomes in COVID-19
por: Dufour, Inès, et al.
Publicado: (2021)

The great help of a virus in the fight against bacteria!
por: Jadoul, Michel, et al.
Publicado: (2021)

Urine metabolomics links dysregulation of the tryptophan-kynurenine pathway to inflammation and severity of COVID-19
por: Dewulf, Joseph P., et al.
Publicado: (2022)

Immunogenicity of a BNT162b2 vaccine booster in health-care workers
por: Saiag, Esther, et al.
Publicado: (2021)

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
por: Frenck, Robert W., et al.
Publicado: (2021)

Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
por: Zurac, Sabina, et al.
Publicado: (2022)

Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults
por: Priddy, Frances H., et al.
Publicado: (2022)

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
por: Payne, Rebecca P., et al.
Publicado: (2021)

Safety and Long-Term Immunogenicity of BNT162b2 Vaccine in Individuals with Down Syndrome
por: Valentini, Diletta, et al.
Publicado: (2022)

Humoral and Cellular Immunogenicity of 3 Doses of BNT162b2 in Children With Kidney Diseases
por: Leung, Daniel, et al.
Publicado: (2023)

Antibody titres decline 3-month post-vaccination with BNT162b2
por: Favresse, Julien, et al.
Publicado: (2021)

Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis
por: Scohy, Anaïs, et al.
Publicado: (2020)

Usefulness of a multiplex immunodot in case of discordant results between automated COVID-19 serological assays
por: Soleimani, Reza, et al.
Publicado: (2021)

Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy
por: Henrivaux, Philippe, et al.
Publicado: (2010)

Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19—BNT162b2 mRNA Vaccination
por: Catry, Emilie, et al.
Publicado: (2022)

Development of SARS-CoV2 humoral response including neutralizing antibodies is not sufficient to protect patients against fatal infection
por: Choteau, Mathilde, et al.
Publicado: (2022)

Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience
por: Peled, Yael, et al.
Publicado: (2022)

Immunogenicity of BNT162b2 mRNA COVID-19 Vaccine in Patients with Cardiovascular Disease
por: Naruse, Hiroyuki, et al.
Publicado: (2021)

Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis
por: Karampitsakos, Theodoros, et al.
Publicado: (2022)

Immunogenicity of the COVID-19 BNT162b2 vaccine in adolescents and young adults with cystic fibrosis
por: Michos, Athanasios, et al.
Publicado: (2022)

Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID‐19 vaccines in Hong Kong
por: Mok, Chris Ka Pun, et al.
Publicado: (2021)

Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
por: Murdoch, Louise, et al.
Publicado: (2023)

Transient blindness and seizures in severe lupus nephritis
por: Morelle, Johann, et al.
Publicado: (2009)

Safety, Efficacy, and Relapse of Nirmatrelvir-Ritonavir in Kidney Transplant Recipients Infected With SARS-CoV-2
por: Devresse, Arnaud, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8oc17c00vskscmf2o82e2h0m3g